An Arg528His Mutation of the CACNL1A3 Gene in a Korean Family with Hypokalemic Periodic Paralysis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Familial hypokalemic periodic paralysis (HOPP) is an autosomal dominant disorder characterized by episodic attacks of muscle weakness with concomitant hypokalemia (<3.5 mEq/L). The onset of HOPP usually occurs within the first and second decade of life. Mutations in the skeletal muscle calcium (CACNL1A3 ) and sodium channel (SCN4A) genes have been reported to be responsible for familial HOPP. Voltage-sensitive ion channels mediate action potentials in electrically excitable cells and play important roles in signal transduction in other cell types. Therefore, abnormalities in a channel's function lead to disarray of signal transduction and thus various neurological symptoms. Those are called channel diseases, which include familial HOPP. We report a 14-year-old boy with HOPP from a family in which two members of two generations are affected. Genetic examination identified a mutation causing a codon change from arginine to histidine at the amino acid portion #528 (R528H) in the calcium channel gene CACNL1A3.
Abstract
Familial hypokalemic periodic paralysis (HOPP) is an autosomal dominant disorder characterized by episodic attacks of muscle weakness with concomitant hypokalemia (<3.5 mEq/L). The onset of HOPP usually occurs within the first and second decade of life. Mutations in the skeletal muscle calcium (CACNL1A3 ) and sodium channel (SCN4A) genes have been reported to be responsible for familial HOPP. Voltage-sensitive ion channels mediate action potentials in electrically excitable cells and play important roles in signal transduction in other cell types. Therefore, abnormalities in a channel's function lead to disarray of signal transduction and thus various neurological symptoms. Those are called channel diseases, which include familial HOPP. We report a 14-year-old boy with HOPP from a family in which two members of two generations are affected. Genetic examination identified a mutation causing a codon change from arginine to histidine at the amino acid portion #528 (R528H) in the calcium channel gene CACNL1A3.
참고문헌 (20)
- Jen J, "Metabolic and molecular bases of inherited disease", pp.5223~5238 (2001), McGraw-Hill
- Lapie P, "Hypokalemic periodic paralysis: an autosomal dominant muscle disorder caused by mutations in a voltage-gated calcium channel", Neuromuscul Disord, 7, pp.234~240 (1997)
- Sternberg D, "Hypokalemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A", Brain, 124, pp.1091~1099 (2001)
- Fontain B, "Mapping of hypokalemic periodic paralysis locus to chromosome 1q31-q32 in three European families", Nat Genet, 6, pp.267~272 (1994)
- Grosson CL, "Hypokalemic periodic paralysis mutations: confirmation of mutation and analysis of founder effect", Neuromuscul Disord, 6, pp.27~31 (1996)
- Fouad G, "Genotype-phenotype correlations of DHP receptor alpha 1-subunit gene mutations causing hypokalemic periodic paralysis", Neuromusc Disord, 7, pp.33~38 (1997)
- 김명규, "채널병의 유전학: 가족형주기성마비", 대한신경과학회지, 23(6), pp.737~744 (2005), 대한신경과학회
- Catteral WA, "Structure and function of voltagesensitive ion channels", Science, 242, pp.50~61 (1998)
- Perez-Reyes E, "Introduction of calcium currents by the expression of the alpha1-subunit of the dihydropyridine receptor from skeletal muscle", Nature, 340, pp.233~236 (1989)
- Jurkat-Rott K, "A calcium channel mutation causing hypokalemic periodic paralysis", Hum Mol Genet, 3, pp.1415~1419 (1994)
- Ptacek LJ, "Dihydropyridine receptor mutations cause hypokalemic periodic paralysis", Cell, 77, pp.863~868 (1994)
- Bulman DE, "A novel sodium channel mutation in a family with hypokalemic periodic paralysis", Neurology, 53, pp.1932~1936 (1999)
- 김준범, "The Genotype and Clinical Phenotype of Korean Patients with Familial Hypokalemic Periodic Paralysis", Journal of Korean Medical Science, 22(6), pp.946~951 (2007), 대한의학회
- Elbaz A, "Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype", phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 caucasian families, 1995, pp.56, 374~380
- Ke Q, "The mutation R672H in SCN4A gene exists in Chinese patients with hypokalemic periodic paralysis", Zhonghua Yi Xue Za Zhi, 86, pp.724~727 (2006)
- Links TP, "Familial hypokalemic periodic paralysis. Clinical, diagnostic and therapeutic aspects", J Neurol Sci, 122, pp.33~43 (1994)
- Bendahhou S, "Sodium channel inactivation defects are associated with acetazolamide-exacerbated hypokalemic periodic paralysis", Ann Neurol, 50, pp.417~420 (2001)
- Poskanzer DC, "Periodic paralysis with response to spironolactone", Lancet, 2, pp.511~513 (1961)
- Torres CF, "Hypokalemic periodic paralysis exacerbated by acetazolamide", Neurology, 31, pp.1423~1428 (1981)
- Rischbieth RH, "Hypokalemic periodic paralysis unresponsive to acetazolamide", Clin Exp Neurol, 18, pp.87~90 (1981)